Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Semin Oncol. 2015 Sep 8;43(1):173–188. doi: 10.1053/j.seminoncol.2015.09.011

Figure 2. Gaps in implementation of combination antiretroviral therapy.

Figure 2

Populations infected with HIV are heterogeneous in terms of time with uncontrolled HIV viremia, extent of immune depletion, and time on antiretroviral therapy (cART). Globally, percent of HIV-infected patients on cART varies between countries and is increasing over time. Presented data is based on 2011 United States estimates. Further cancer prevention through increased cART coverage is likely achievable. Considerations regarding effects of timing of initiation of cART on cancer risk factors are noted.